Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026)

Kestra Medical Technologies' (KMTS) quarterly Return on Capital Employed came in at 42.3% in Q2 2026, up 2261.0% year-on-year from 1.79% in Q2 2025, and up 20.44% on a QoQ basis from 53.17% in Q1 2026.

Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026) Analysis & Trends

Kestra Medical Technologies (KMTS) has 2 years of Return on Capital Employed data on file, last reported at 42.3% in Q2 2026.

  • On a quarterly basis, Return on Capital Employed rose 2261.0% year-over-year to 42.3% in Q2 2026; TTM through Apr 2026 was 42.3%, a 2261.0% increase from a year earlier, with the FY2026 full-year figure at 48.69%, up 3137.0% from the prior year.
  • Return on Capital Employed for Q2 2026 stood at 42.3%, up from 53.17% in the prior quarter.
  • Over the last five years, Return on Capital Employed for KMTS reached as high as 42.3% in Q2 2026 and fell as low as 64.91% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 28.56%
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 18.58%
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 5.02%
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 25.95%
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 19.71%
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.68%
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 19.44%
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 12.74%
10 Kestra Medical Technologies 1.17 Bn 809.84 Mn 15.68 Mn -42.30%

Historic Data

Download Data
DateValue
Apr 30, 2026 -42.30%
Jan 31, 2026 -53.17%
Oct 31, 2025 -58.64%
Jul 31, 2025 -46.96%
Apr 30, 2025 -64.91%